Tazicef - 0409-5084-51 - (CEFTAZIDIME)

Alphabetical Index


Drug Information of Tazicef

Product NDC: 0409-5084
Proprietary Name: Tazicef
Non Proprietary Name: CEFTAZIDIME
Active Ingredient(s): 2    g/1 & nbsp;   CEFTAZIDIME
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Tazicef

Product NDC: 0409-5084
Labeler Name: Hospira, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA062662
Marketing Category: ANDA
Start Marketing Date: 20120305

Package Information of Tazicef

Package NDC: 0409-5084-51
Package Description: 10 VIAL in 1 TRAY (0409-5084-51) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL

NDC Information of Tazicef

NDC Code 0409-5084-51
Proprietary Name Tazicef
Package Description 10 VIAL in 1 TRAY (0409-5084-51) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Product NDC 0409-5084
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name CEFTAZIDIME
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20120305
Marketing Category Name ANDA
Labeler Name Hospira, Inc.
Substance Name CEFTAZIDIME
Strength Number 2
Strength Unit g/1
Pharmaceutical Classes Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]

Complete Information of Tazicef


General Information